Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

9.3%

7 terminated/withdrawn out of 75 trials

Success Rate

86.8%

+0.3% vs industry average

Late-Stage Pipeline

23%

17 trials in Phase 3/4

Results Transparency

0 of 46 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A

32(59.3%)

Phase 4

10(18.5%)

Phase 3

7(13.0%)

Phase 2

5(9.3%)

54Total

N/A(32)

Phase 4(10)

Phase 3(7)

Phase 2(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (75)

Showing 20 of 75 trials

NCT07548268Not ApplicableRecruiting

Transoral and Cervical Ultrasound of Patients With Suspected Oropharyngeal Cancer

Role: collaborator

NCT06667999Phase 4Recruiting

The Intensive Care Platform Trial

Role: collaborator

NCT05664945Not ApplicableActive Not Recruiting

Rethinking Pulmonary Rehabilitation - a Three-arm Randomised Multicentre Trial

Role: collaborator

NCT06645015Not ApplicableRecruiting

The AIDPRO-CRC Trial

Role: collaborator

NCT04916132Recruiting

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Role: collaborator

NCT06813638Completed

Pain Management After Cesarean Section - A Before-and-After Cohort Study

Role: collaborator

NCT04632303Not ApplicableActive Not Recruiting

Early Palliative Care for Patients With Advanced Pancreatic Cancer.

Role: collaborator

NCT04688788Phase 3Active Not Recruiting

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Role: collaborator

NCT03795220Phase 4Completed

Preparing and Timing of the Endometrium in Modified Natural Cycle Frozen-thawed Embryo Transfers

Role: collaborator

NCT04075461Not ApplicableCompleted

Arthroplasty Versus Internal Fixation for Undisplaced Femoral Neck Fracture

Role: collaborator

NCT04008810Completed

Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease

Role: lead

NCT01611896Not ApplicableCompleted

Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism

Role: collaborator

NCT05042973Phase 2Completed

The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure

Role: collaborator

NCT05084235Phase 2Completed

The Cardiac Effects of Empagliflozin in Patients With High Risk of Heart Failure

Role: collaborator

NCT05569980Enrolling By Invitation

The Nordic Rectal Prolapse Study

Role: collaborator

NCT06082063Phase 3Recruiting

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Role: collaborator

NCT03956173Completed

Hypoglycemia and Cardiac Arrhythmias in Type 1 Diabetes

Role: collaborator

NCT04841304Active Not Recruiting

Cardiac Arrhythmia in Patients with End-Stage Renal Disease

Role: collaborator

NCT04088292Phase 3Active Not Recruiting

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

Role: collaborator

NCT06637618Not ApplicableNot Yet Recruiting

Does the Sequence of Heart Failure Medication Matter

Role: collaborator